Bioptimus
PrivateLast Round
Series A
Jan 14, 2025
Total Funding Raised
$117M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bioptimus is a biotechnology and artificial intelligence company that develops a universal AI foundation model to enhance scientific research and drive biotechnological innovation by transforming multiscale biological data into actionable insights.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, ML Platforms, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioptimus Comparables
Compare Bioptimus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvolutionaryScale | 84% | |
| Aignostics | 82% | |
| Tahoe Therapeutics | 81% | |
Bioptimus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 14, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Seed | Feb 20, 2024 |
Key People
Founding team and executive leadership
Bioptimus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Series A |
| Top Harvest Capital | Seed |
| HV Fund | Series A |
| NJF Capital | Seed |
| Andera Partners | Series A |
| Top Harvest Capital | Seed |
| Pomifer Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 40% MoM, reaching 19K.
- Jul 20, 2026
Open roles increased to 63, 3.4x the trailing average.
Bioptimus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioptimus's valuation, stock price, and market status.